Isabelle brings 17 years of international experience in life sciences business development and finance.
Isabelle started her career in ’91 at Arthur Andersen Detroit, US then at Pfizer France and Europe where she held several positions during 6 years in the field of management accounting, clinical research then Business Development. Since ’98, she was Associate Director of Business Development at Fournier and signed several deals in Europe and in the US.
Isabelle graduated as an engineer from Ecole Centrale of Paris and holds DECF and ISEB degrees and joigned Seventure in July 2001. Isabelle de Cremoux is a board member of Fluxome Sciences, Vivolution, Meristem Therapeutics and OPi Pharma and manages investments in Santaris Pharma and Noxxon Pharma.
